Treatment of adult gonococcal keratoconjunctivitis with oral norfloxacin.
We evaluated the efficacy of oral norfloxacin in 15 patients with culture-proven gonococcal eye disease caused by Neisseria gonorrhoeae. The first seven patients received 1,200 mg of oral norfloxacin for three consecutive days. The other eight patients were each treated with a single oral dose of 1,200 mg of norfloxacin. All control cultures were negative, and there was no progression of the corneal lesions after treatment was initiated. No adverse effects were observed. The results of this study suggested that a single dose of oral norfloxacin may be a valuable alternative to the currently recommended treatment regimens for gonococcal eye disease because it combines high efficacy and low toxicity with low cost and excellent patient compliance.
Kestelyn
P
P
Department of Ophthalmology, Centre Hospitalier de Kigali, Rwanda.
Bogaerts
J
J
Stevens
A M
AM
Piot
P
P
Meheus
A
A
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D002986:Clinical Trials as Topic; D003228:Conjunctiva / Q000382:microbiology; D015818:Eye Infections, Bacterial / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D005500:Follow-Up Studies; D006801:Humans; D007637:Keratoconjunctivitis / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D008297:Male; D009344:Neisseria gonorrhoeae / Q000302:isolation & purification*; D009643:Norfloxacin / Q000008:administration & dosage / Q000627:therapeutic use*; D010781:Photography; D014521:Urethra / Q000382:microbiology
D009643:Norfloxacin